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Abstract
Lecithin cholesterol acyltransferase (LCAT) is a plasma enzyme that remodels
nascent high density lipoprotein (HDL) into a mature form called spherical HDL.
The impeding of this critical step in reverse cholesterol transport (RCT, the
transport of cholesterol from periphery cells to liver), leads to atherosclerosis.
Our goal is to use computational chemistry and molecular modeling tools to
build molecular models for LCAT and its complex with nascent HDL. The
molecular models are constructed from low resolution structures of LCAT and
LCAT-HDL complex obtained by small angle neutron scattering (SANS) with
contrast variation. Ultimately, we combine various experimental data (SANS
data, hydrogen-deuterium exchange tandem mass spectrometry, other
biochemical data) with computational techniques (bioinformatics, molecular
modeling, SANS modeling, protein-protein docking, molecular dynamics
simulation) to produce a molecular model for LCAT and its complex with nascent
HDL. The model will be used in the future to map the amino acid residues from
LCAT and the protein component of nascent HDL (apoA1) involved in mutual
interaction, and to identify LCAT residues interacting with the lipid phase of
nascent HDL.

